Literature DB >> 23181598

Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans.

T Wu1, M J Bound, S D Standfield, B Gedulin, K L Jones, M Horowitz, C K Rayner.   

Abstract

Glucagon-like peptide-1 (GLP-1) and peptide YY (PYY), secreted by enteroendocrine L-cells located most densely in the colon and rectum, are of fundamental importance in blood glucose and appetite regulation. In animal models, colonic administration of bile acids can stimulate GLP-1 and PYY by TGR5 receptor activation. We evaluated the effects of taurocholic acid (TCA), administered as an enema, on plasma GLP-1 and PYY, as well as gastrointestinal sensations in 10 healthy male subjects, and observed that rectal administration of TCA promptly stimulated secretion of both GLP-1 and PYY, and increased fullness, in a dose-dependent manner. These observations confirm that topical application of bile acids to the distal gut may have potential for the management of type 2 diabetes and obesity.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23181598     DOI: 10.1111/dom.12043

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  41 in total

1.  Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.

Authors:  Emilie Bahne; Emily W L Sun; Richard L Young; Morten Hansen; David P Sonne; Jakob S Hansen; Ulrich Rohde; Alice P Liou; Margaret L Jackson; Dayan de Fontgalland; Philippa Rabbitt; Paul Hollington; Luigi Sposato; Steven Due; David A Wattchow; Jens F Rehfeld; Jens J Holst; Damien J Keating; Tina Vilsbøll; Filip K Knop
Journal:  JCI Insight       Date:  2018-12-06

2.  Do colorectal cancer resections improve diabetes in long-term survivors? A case-control study.

Authors:  Joel Faintuch; Silvia Y Hayashi; Sergio C Nahas; Osmar K Yagi; Salomao Faintuch; Ivan Cecconello
Journal:  Surg Endosc       Date:  2013-11-01       Impact factor: 4.584

3.  Bile Acid Receptors and Gastrointestinal Functions.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Liver Res       Date:  2019-01-14

Review 4.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 5.  Energy metabolism in cachexia.

Authors:  Maria Rohm; Anja Zeigerer; Juliano Machado; Stephan Herzig
Journal:  EMBO Rep       Date:  2019-03-19       Impact factor: 8.807

Review 6.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

Review 7.  The Gut as an Endocrine Organ: Role in the Regulation of Food Intake and Body Weight.

Authors:  Audrey Melvin; Carel W le Roux; Neil G Docherty
Journal:  Curr Atheroscler Rep       Date:  2016-08       Impact factor: 5.113

Review 8.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

9.  Comparative Effects of Bile Diversion and Duodenal-Jejunal Bypass on Glucose and Lipid Metabolism in Male Diabetic Rats.

Authors:  Xiang Zhang; Teng Liu; Yanmin Wang; Mingwei Zhong; Guangyong Zhang; Shaozhuang Liu; Tongzhi Wu; Christopher K Rayner; Sanyuan Hu
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

10.  Duodenal-Jejunal Bypass Preferentially Elevates Serum Taurine-Conjugated Bile Acids and Alters Gut Microbiota in a Diabetic Rat Model.

Authors:  Xiang Zhang; Yanmin Wang; Mingwei Zhong; Teng Liu; Haifeng Han; Guangyong Zhang; Shaozhuang Liu; Meng Wei; Qunzheng Wu; Sanyuan Hu
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.